Item Type | Name |
Concept
|
American Cancer Society
|
Concept
|
Carcinoma, Squamous Cell
|
Concept
|
Drug Synergism
|
Concept
|
Decision Support Techniques
|
Concept
|
Educational Status
|
Concept
|
Health Services for the Aged
|
Concept
|
Mass Screening
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Health Services Accessibility
|
Concept
|
Health Services Misuse
|
Concept
|
Intensive Care Units
|
Concept
|
Neoplasm Staging
|
Concept
|
Social Support
|
Concept
|
Cohort Studies
|
Concept
|
Genes, ras
|
Concept
|
Specialization
|
Concept
|
Social Class
|
Concept
|
Societies, Medical
|
Concept
|
Statistics as Topic
|
Concept
|
United States
|
Concept
|
Urban Population
|
Concept
|
Multicenter Studies as Topic
|
Concept
|
Neoplasms, Second Primary
|
Concept
|
Salvage Therapy
|
Concept
|
Cost Savings
|
Concept
|
Case-Control Studies
|
Concept
|
Decision Support Systems, Clinical
|
Concept
|
src-Family Kinases
|
Concept
|
Self Efficacy
|
Concept
|
Genetic Association Studies
|
Concept
|
Self Report
|
Concept
|
Sirolimus
|
Concept
|
Surveys and Questionnaires
|
Concept
|
National Cancer Institute (U.S.)
|
Concept
|
Health Status Disparities
|
Concept
|
Snake Venoms
|
Concept
|
Social Justice
|
Concept
|
Socioeconomic Factors
|
Concept
|
Stomach Neoplasms
|
Concept
|
TOR Serine-Threonine Kinases
|
Concept
|
Sex Factors
|
Concept
|
Models, Statistical
|
Concept
|
Survival Analysis
|
Concept
|
Survival Rate
|
Concept
|
Patient Selection
|
Concept
|
Cost Sharing
|
Concept
|
SEER Program
|
Concept
|
Health Care Surveys
|
Concept
|
Medical Order Entry Systems
|
Concept
|
Spirituality
|
Concept
|
Ribosomal Protein S6 Kinases, 70-kDa
|
Concept
|
Drug Administration Schedule
|
Concept
|
Follow-Up Studies
|
Concept
|
Health Services Research
|
Concept
|
Life Style
|
Concept
|
Longitudinal Studies
|
Concept
|
Prospective Studies
|
Concept
|
Retrospective Studies
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Disease-Free Survival
|
Concept
|
Point-of-Care Systems
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Spiritual Therapies
|
Concept
|
Patient Safety
|
Academic Article
|
Breast cancer and race: a rising tide does not lift all boats equally.
|
Academic Article
|
Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites.
|
Academic Article
|
Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries.
|
Academic Article
|
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
|
Academic Article
|
Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial.
|
Academic Article
|
Triple-negative breast cancers: a view from 10,000 feet.
|
Academic Article
|
Personalized colon cancer care in 2010.
|
Academic Article
|
Race and subset analyses in clinical trials: time to get serious about data integration.
|
Academic Article
|
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinoma.
|
Academic Article
|
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium.
|
Academic Article
|
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.
|
Academic Article
|
Infused chemotherapy use in the elderly after patent expiration.
|
Academic Article
|
Infused chemotherapy use in the elderly after patent expiration.
|
Academic Article
|
Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review.
|
Academic Article
|
Predictors of competing mortality in advanced head and neck cancer.
|
Academic Article
|
Colorectal cancer model of health disparities: understanding mortality differences in minority populations.
|
Academic Article
|
Predictors of competing mortality in early breast cancer.
|
Academic Article
|
Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution.
|
Academic Article
|
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.
|
Academic Article
|
Value-based insurance design in oncology.
|
Academic Article
|
Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE).
|
Academic Article
|
American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities.
|
Academic Article
|
Unsupported off-label chemotherapy in metastatic colon cancer.
|
Academic Article
|
Achieving health equity in colorectal cancer: a call to action.
|
Academic Article
|
Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignancies.
|
Academic Article
|
American Society of Clinical Oncology policy statement on medicaid reform.
|
Academic Article
|
The role of statins for primary prevention in non-elderly colorectal cancer patients.
|
Academic Article
|
States as the laboratory for democracy: is anybody paying attention, and does anybody care?
|
Academic Article
|
Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer.
|
Academic Article
|
Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.
|
Academic Article
|
Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
|
Academic Article
|
Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes.
|
Academic Article
|
The Vulnerable Elders Survey-13 predicts mortality in older adults with later-stage colorectal cancer receiving chemotherapy: a prospective pilot study.
|
Academic Article
|
Combined-modality therapy for rectal cancer: analysis of potential differences in disease presentation, treatment adherence, and treatment outcome according to race.
|
Academic Article
|
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.
|
Academic Article
|
Achieving a deeper understanding of the implemented provisions of the Affordable Care Act.
|
Academic Article
|
Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist.
|
Academic Article
|
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.
|
Academic Article
|
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
|
Academic Article
|
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.
|
Academic Article
|
Oncology Pathways-Preventing a Good Idea From Going Bad.
|
Academic Article
|
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance).
|
Academic Article
|
A Pathway Through the Bundle Jungle.
|
Academic Article
|
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.
|
Academic Article
|
No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations.
|
Academic Article
|
Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer.
|
Academic Article
|
Evaluating screening colonoscopy quality in an uninsured urban population following patient navigation.
|
Academic Article
|
A phase II study of imatinib mesylate (IM) and interferon-alpha (IFNA) in metastatic renal cell carcinoma (RCC).
|
Academic Article
|
An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population.
|
Academic Article
|
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
|
Academic Article
|
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
|
Academic Article
|
Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer.
|
Academic Article
|
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
|
Academic Article
|
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
|
Academic Article
|
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
|
Academic Article
|
Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations.
|
Academic Article
|
Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.
|
Academic Article
|
Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study.
|
Academic Article
|
Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.
|
Academic Article
|
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial.
|
Academic Article
|
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study.
|
Academic Article
|
A New Look at the State of Cancer Care in America.
|
Academic Article
|
Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial.
|
Academic Article
|
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.
|
Academic Article
|
Impact on Oncology Practices of Including Drug Costs in Bundled Payments.
|
Academic Article
|
Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes.
|
Academic Article
|
The Road From Theory to Reality: Illuminating the Complexity of Prospective Cancer Bundles.
|
Academic Article
|
A Rules-Based Algorithm to Prioritize Poor Prognosis Cancer Patients in Need of Advance Care Planning.
|
Academic Article
|
The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey.
|
Academic Article
|
Blase Polite on How Disparities Research Must Move Into an Era of Action.
|
Academic Article
|
Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.
|
Academic Article
|
Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.
|
Academic Article
|
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
|
Academic Article
|
State of Cancer Care in America: Reflections on an Inaugural Year.
|
Academic Article
|
Investigation of a multimedia, computer-based approach to improve knowledge, attitudes, self-efficacy, and receptivity to cancer clinical trials among newly diagnosed patients with diverse health literacy skills.
|
Academic Article
|
Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer.
|
Academic Article
|
Opaque Results of Federal Price Transparency Rules and State-Based Alternatives.
|
Academic Article
|
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
|
Academic Article
|
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting.
|
Academic Article
|
Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.
|
Academic Article
|
Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases.
|
Academic Article
|
"Let Go, Let God": A Qualitative Study Exploring Cancer Patients' Spirituality and Its Place in the Medical Setting.
|
Academic Article
|
Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban Setting.
|
Academic Article
|
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial.
|
Academic Article
|
Gender- and Race-Based Differences in Barriers and Facilitators to Early Detection of Colon Cancer.
|
Academic Article
|
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance).
|
Academic Article
|
Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies.
|
Academic Article
|
Bending Versus Transforming the Drug Cost Curve: A Matter of Political Will.
|
Academic Article
|
Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-Grade Appendiceal Ex-Goblet Adenocarcinoma.
|
Academic Article
|
Oncology's "Hockey Stick" Moment for the Cost of Cancer Drugs-The Climate Is About to Change.
|
Academic Article
|
Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial.
|
Academic Article
|
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease.
|
Academic Article
|
Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405.
|
Academic Article
|
Cytoreductive Surgery for Selected Patients Whose Metastatic Gastric Cancer was Treated with Systemic Chemotherapy.
|
Academic Article
|
IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
|
Academic Article
|
Improving End of Life Cancer Outcomes Through Development and Implementation of a Spiritual Care Advocate Program.
|
Academic Article
|
Health Insurance Status as a Predictor of Mode of Colon Cancer Detection but Not Stage at Diagnosis: Implications for Early Detection.
|
Academic Article
|
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
|
Academic Article
|
Oncology Medical Home: ASCO and COA Standards.
|
Academic Article
|
Intra-Operative Radiation Therapy and Surgical Excision for Locally Recurrent Gastrointestinal Cancers: Initial Results of a Single-Institution Registry.
|
Academic Article
|
Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative.
|
Academic Article
|
Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination.
|
Academic Article
|
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels.
|
Academic Article
|
Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis.
|
Academic Article
|
ASO Author Reflections: The Utility of Circulating-Tumor DNA in Selecting Patients for Locoregional, Metastases-Directed Therapies in Oligometastatic Foregut Adenocarcinoma.
|
Academic Article
|
Oncology alternative payment models: lessons from commercial insurance.
|
Academic Article
|
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.
|
Academic Article
|
Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405.
|
Academic Article
|
Survival in Total Preoperative vs. Perioperative Chemotherapy for Patients with Metastatic High-Grade Appendiceal Adenocarcinoma Undergoing CRS/HIPEC.
|
Academic Article
|
Intra-operative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry.
|
Academic Article
|
ASO Visual Abstract: Intraoperative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry.
|
Academic Article
|
Evaluating the Addition of Clinical and Staging Data to Improve the Pricing Methodology of the Oncology Care Model.
|
Academic Article
|
Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases.
|
Academic Article
|
ASO Visual Abstract: PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence for Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
|
Academic Article
|
PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
|
Concept
|
Surgical Oncology
|
Concept
|
Stakeholder Participation
|
Concept
|
Cytoreduction Surgical Procedures
|
Concept
|
Response Evaluation Criteria in Solid Tumors
|
Academic Article
|
Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent Surgery.
|
Academic Article
|
Doublet vs. Triplet Systemic Chemotherapy for High Grade Appendiceal Adenocarcinoma with Peritoneal Metastases.
|
Academic Article
|
Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastases.
|
Academic Article
|
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.
|
Academic Article
|
Early Integrated Palliative Care Within a Surgical Oncology Clinic.
|
Academic Article
|
The Promise of Cancer Health Justice: How Stakeholders and the Community Can Build a Sustained and Equitable System of Cancer Care Through the Lens of Colorectal Cancer Interventions.
|
Academic Article
|
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.
|